Sutter Health Plus
Adlyxin (lixisenatide)
Hormones : Drugs for Diabetes
  • Acromegaly:
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Reauthorization Required: No
    Duration of Reauthorization: N/A

    Neuroendocrine Tumor (NET):
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A

    Oncology: Carcinoid Syndrome:
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A
    Requires diagnosis of Carcinoid syndrome with diarrhea: No
    Concomitant Therapy Required with Somatostatin Analog Therapy: No
    Patient Required to Try Increased Dosage of Sandostatin: No

  • Step Therapy: Neutropenia:
    ST Multiple Brands

  • Step Therapy: Cluster Headache:
    ST Single Generic

    Migraine Prevention:
    ST Multiple Generics

  • NSCLC EGFR Mutated:
    Duration: 1 year(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A

  • PA_APPLIES
  • Quantity Limit: 1 dose pack per 365 day(s).